Perkins Capital Management’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Perkins Capital Management’s Portfolio AUGX Stock Details AUGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,417,068	Closed	-$1.25M	–	91
2024 Q2	$1.25M	Sell	1,417,068 -41,200	-3%	-$85K	1.18%	27
2024 Q1	$5.96M	Sell	1,458,268 -6,300	-0.4%	-$28.2K	4.97%	3
2023 Q4	$8.57M	Buy	1,464,568 +73,475	+5%	+$387K	7.32%	1
2023 Q3	$7.16M	Sell	1,391,093 -149,900	-10%	-$703K	7.1%	1
2023 Q2	$7.41M	Sell	1,540,993 -95,850	-6%	-$332K	6.46%	1
2023 Q1	$2.85M	Sell	1,636,843 -43,585	-3%	-$71.1K	2.69%	8
2022 Q4	$2.62M	Buy	1,680,428 +1,233,528	+276%	+$1.57M	2.77%	9
2022 Q3	$648K	Buy	446,900 +7,400	+2%	+$12.7K	0.73%	45
2022 Q2	$791K	Buy	439,500 +10,500	+2%	+$24.3K	0.82%	46
2022 Q1	$1.26M	Hold	429,000	–	–	1.03%	40
2021 Q4	$1.35M	Buy	+429,000	New	+$1.55M	0.91%	40

Other funds holding AUGX

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Samjo Management New York $293M AUM 57.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return

HIM

HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Perkins Capital Management's AUGX Position: Q3 2024 in Review

Perkins Capital Management sold out of Augmedix, Inc. Common Stock (AUGX) in Q3 2024, closing a stake of 1,417,068 shares — an estimated $1.25M sold.

Perkins Capital Management first reported a position in AUGX in Q4 2021 and held it in 11 quarters. The position peaked at $8.57M in Q4 2023. 45 funds tracked by Wall St. Rank hold AUGX as of Q3 2024.

Perkins Capital Management reported no remaining Augmedix, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Perkins Capital Management sold 1,417,068 Augmedix, Inc. Common Stock shares in Q3 2024, an estimated $1.25M.
Perkins Capital Management first reported a position in Augmedix, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
Perkins Capital Management's Augmedix, Inc. Common Stock position peaked at $8.57M in Q4 2023.
45 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q3 2024.

Based on Perkins Capital Management's 13F filing for Q3 2024, filed 31 Oct 2024.